Overview

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

Status:
RECRUITING
Trial end date:
2027-01-31
Target enrollment:
Participant gender:
Summary
To evaluate the long-term safety and tolerability of cenobamate in Japanese epilepsy patients with partial seizures
Phase:
PHASE2
Details
Lead Sponsor:
Ono Pharmaceutical Co. Ltd
Treatments:
Cenobamate